1. Home
  2. MUX vs PGEN Comparison

MUX vs PGEN Comparison

Compare MUX & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo McEwen Mining Inc.

MUX

McEwen Mining Inc.

HOLD

Current Price

$21.84

Market Cap

1.6B

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$4.38

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MUX
PGEN
Founded
1979
1998
Country
Canada
United States
Employees
1432
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.4B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
MUX
PGEN
Price
$21.84
$4.38
Analyst Decision
Strong Buy
Buy
Analyst Count
4
5
Target Price
$26.63
$8.33
AVG Volume (30 Days)
1.0M
3.3M
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$230,981,000.00
Revenue This Year
$37.86
$1,115.92
Revenue Next Year
$31.10
$81.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.25
$1.28
52 Week High
$29.70
$5.47

Technical Indicators

Market Signals
Indicator
MUX
PGEN
Relative Strength Index (RSI) 46.83 55.30
Support Level $20.43 $3.96
Resistance Level $26.30 $4.40
Average True Range (ATR) 1.25 0.27
MACD -0.17 0.01
Stochastic Oscillator 23.39 46.74

Price Performance

Historical Comparison
MUX
PGEN

About MUX McEwen Mining Inc.

McEwen Inc, formerly McEwen Mining Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. More than half of the company's gold output comes from the El Gallo 1 mine, while the remaining gold production and the majority of silver production are sourced from the San Jose mine. Geographically, majority of production occurs in the United States.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: